TW267103B - - Google Patents

Info

Publication number
TW267103B
TW267103B TW082102678A TW82102678A TW267103B TW 267103 B TW267103 B TW 267103B TW 082102678 A TW082102678 A TW 082102678A TW 82102678 A TW82102678 A TW 82102678A TW 267103 B TW267103 B TW 267103B
Authority
TW
Taiwan
Prior art keywords
itraconazole
phospholipid
formulation
preparing
water
Prior art date
Application number
TW082102678A
Other languages
English (en)
Original Assignee
Janssen Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Farmaceutici Spa filed Critical Janssen Farmaceutici Spa
Application granted granted Critical
Publication of TW267103B publication Critical patent/TW267103B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW082102678A 1992-02-12 1993-04-10 TW267103B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200397 1992-02-12

Publications (1)

Publication Number Publication Date
TW267103B true TW267103B (zh) 1996-01-01

Family

ID=8210419

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102678A TW267103B (zh) 1992-02-12 1993-04-10

Country Status (17)

Country Link
EP (1) EP0625899B1 (zh)
JP (1) JPH07503953A (zh)
KR (1) KR940703651A (zh)
CN (1) CN1076614A (zh)
AT (1) ATE138561T1 (zh)
AU (1) AU661754B2 (zh)
CA (1) CA2129828A1 (zh)
DE (1) DE69302897T2 (zh)
DK (1) DK0625899T3 (zh)
ES (1) ES2091019T3 (zh)
GR (1) GR3020695T3 (zh)
IL (1) IL104689A (zh)
MX (1) MX9300708A (zh)
MY (1) MY131524A (zh)
TW (1) TW267103B (zh)
WO (1) WO1993015719A1 (zh)
ZA (1) ZA93955B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438601B (en) * 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
EP1039909B1 (en) 1997-12-31 2002-10-09 Choongwae Pharma Corporation Method of production and composition of an oral preparation of itraconazole
US6497905B1 (en) 1999-03-24 2002-12-24 R.P. Scherer Technologies, Inc. Aqueous solubility pharmaceutical formulations
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
CU23175A1 (es) * 2000-07-17 2006-09-22 Ct De Investigacion Y Desarrol Formulacion liposomica de propionato de clobetasol
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
KR100712734B1 (ko) 2005-05-31 2007-05-04 에이엔에이치 케어연구소(주) 이트라코나졸을 함유하는 피부외용제
KR100970911B1 (ko) * 2007-12-13 2010-07-20 재단법인서울대학교산학협력재단 트리아졸계 항진균제를 함유하는 반고형 외용제 및 이의 제조방법
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
WO2009088959A1 (en) * 2008-01-04 2009-07-16 Brian Charles Keller Enhanced delivery of antifungal agents
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
CN105848719A (zh) 2013-11-22 2016-08-10 道尔医药科学公司 抗感染的方法、组合物和装置
AU2018321287A1 (en) 2017-08-20 2020-04-02 University Of Connecticut Azole analogues and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DE3851842T2 (de) * 1987-10-19 1995-03-02 Liposome Co Inc Wässrige bereitung von liposomenzusammensetzungen.
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
IL104689A (en) 1996-12-05
ES2091019T3 (es) 1996-10-16
MX9300708A (es) 1994-07-29
ATE138561T1 (de) 1996-06-15
DE69302897T2 (de) 1996-09-26
KR940703651A (ko) 1994-12-12
MY131524A (en) 2007-08-30
EP0625899B1 (en) 1996-05-29
GR3020695T3 (en) 1996-10-31
CA2129828A1 (en) 1993-08-19
CN1076614A (zh) 1993-09-29
IL104689A0 (en) 1993-06-10
DE69302897D1 (de) 1996-07-04
EP0625899A1 (en) 1994-11-30
WO1993015719A1 (en) 1993-08-19
AU3453593A (en) 1993-09-03
AU661754B2 (en) 1995-08-03
JPH07503953A (ja) 1995-04-27
DK0625899T3 (da) 1996-06-17
ZA93955B (en) 1994-08-11

Similar Documents

Publication Publication Date Title
TW267103B (zh)
AU639975B2 (en) Topical preparations for treating human nails
HUT62201A (en) Method for producing galen preparations containing cyclosporines as active ingredient
CA2099188A1 (en) Use of a cosmetic composition
MY104412A (en) Acne treatment.
HUP9900935A2 (hu) Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására
TW262382B (zh)
AU3521293A (en) Sterilised whippable non-dairy creams
FR2687913B1 (zh)
AU1542288A (en) Combination of minoxidil and an anti-inflammatory agent for treating patterned alopecia
PT79855B (en) Process for the preparation of indolphenantridines
ZA972180B (en) Topical formulations for the treatment of psoriasis of the nail.
GB9208214D0 (en) The use of oligourethanes as forming agents for aqueous pigment preparations
DE59205958D1 (de) Dose für Kosmetikzubereitungen
IT1255762B (it) Formulazioni liposomiche di piroxicam.
AU5609386A (en) Topical agents for inhibiting the melanin generation
AU7989494A (en) Oil-in-water formulation for topical application
AU5259486A (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
WO1994003148A3 (de) Hautbräunungsmittel
NO178782C (no) Fremgangsmåte for fremstilling av et farmasöytisk akseptabelt gelpreparat
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
PT82421B (en) Process for the preparation of topical agents for inhibiting the melanin generation
AU6271490A (en) Anti-inflammatory active ingredients for cosmetic preparations
GB9308572D0 (en) Topical lotion for the treatment of alopecia
GR860995B (en) Topical agents for inhibiting the melanin generation